Jubilant Life Sciences has reported results for first quarter ended June 30, 2016.
The company has reported more than seven fold jump in its net profit at Rs 20.98 crore for the quarter as compared to Rs 2.84 crore for the same quarter in the previous year. Total income of the company decreased by 13.27% at Rs 591.68 crore for quarter under review as compared to Rs 682.20 crore for the quarter ended June 30, 2015.
On the consolidated basis, the company has reported 22.49% jump in its net profit after tax, minority interest and share of profit of associates at Rs 161.60 crore for the quarter ended June 30, 2016 as compared to Rs 131.93 crore for the same quarter in the previous year. However, total Income of the company decreased by 1.77% to Rs 1423.82 crore for quarter under review from Rs 1449.50 crore for the quarter ended June 30, 2015.
